Clinical Trial Update: Individualizing Corticosteroid Use in Pneumonia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is recruiting to individualize corticosteroid use in pneumonia, exploring personalized treatment strategies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Snippet

Sponsor: Mayo Clinic | Conditions: Pneumonia | Phase 2 | Status: RECRUITING